Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

CORRECTED-US STOCKS-S&P 500, Dow head lower as COVID-19 cases climb; eyes on stimulus

Published 20/07/2020, 13:49
Updated 20/07/2020, 14:54

(Corrects paragraph 10 to remove reference to Amazon.com
reporting quarterly results this week)
* Chevron slips after agreeing to buy Noble Energy for $5
bln
* Halliburton rises after results
* Pfizer up on securing UK supply deal for potential
vaccines
* Futures: Dow down 0.2%, S&P off 0.2%, Nasdaq up 0.3%

By Devik Jain and Medha Singh
July 20 (Reuters) - The S&P 500 and Dow indexes were set to
open lower on Monday as concerns about a jump in COVID-19 cases
curbed risk appetite, with investors also hoping for more
stimulus to shore up a battered global economy.
After the U.S. government's $3 trillion commitment to the
crisis 12 weeks ago, record levels of new infections have forced
many states to backpedal their reopening plans just as those
support programs are due to expire.
At least 14 states have reported record hospitalizations so
far in July and Florida saw 12,000 new cases on Sunday.
Furthermore, the U.S. Centers for Disease Control and Prevention
has warned that cases and deaths could rise this autumn and
winter. Congress is set to debate a new aid package this week.

Positive news related to vaccine development, stimulus talks
in the United States and Europe could be the three catalysts
that help the S&P 500 potentially break through its year-to-date
break even level this week, said Thomas Hayes, managing member
at Great Hill Capital LLC in New York.
Later in the day, all eyes will be on early-stage human
trial data on a vaccine being developed by AstraZeneca Plc
AZN.L and Oxford University. Signs of progress on a potential coronavirus vaccine,
improving economic data and a relatively upbeat start to the
second-quarter earnings season helped the S&P 500 and the Dow
rise for three consecutive weeks.
The benchmark S&P 500 is now less than 5% down from its Feb.
19 record close.
Oilfield services giant Halliburton Co HAL.N rose 5.2%
premarket as it posted a surprise adjusted profit benefiting
from aggressive cost cuts. This week, major companies including Microsoft Corp
MSFT.O , Tesla Inc TSLA.O , Intel Corp INTC.O and Honeywell
International Inc HON.N are expected to report quarterly
results.
At 8:20 a.m. ET, Dow e-minis 1YMcv1 were down 45 points,
or 0.17%. S&P 500 e-minis EScv1 were down 4.75 points, or
0.15% and Nasdaq 100 e-minis NQcv1 were up 26.5 points, or
0.25%.
Noble Energy Inc's NBL.O shares jumped 12.4% as Chevron
Corp CVX.N agreed to buy the Houston-based oil and gas
producer for $5 billion in an all-stock deal. Chevron fell 0.2%.
L3N2ER2FR
Pfizer Inc PFE.N rose 3.3%, after Britain signed deals to
secure 90 million doses of two possible COVID-19 vaccines from
an alliance of the U.S. drugmaker, Germany-based BioNTech
22UAy.F and French group Valneva VLS.PA . Valneva is also in talks with the European Union for a
vaccine supply deal.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.